The top news stories of 2017 included new ACC/AHA High Blood Pressure Guidelines; the first ever guideline for the evaluation and management of patients with syncope; a focused update of guidelines for the treatment of patients with valvular heart disease; the hottest trials from the biggest cardiovascular conferences; and more.

Here is a list of the top ACC.org news stories in 2017:

1. New ACC/AHA High Blood Pressure Guidelines Lower Definition of Hypertension
• ACC High Blood Pressure Guidelines Hub
• Complete AHA 2017 Coverage
2. FOURIER: Evolocumab Significantly Reduces Risk of Cardiovascular Events
   New England Journal of Medicine
• Complete ACC.17 Coverage
3. CVD-REAL Study: Lower Rates of Hospitalization For HF in New Users of SGLT-2 Inhibitors
• Complete ACC.17 Coverage
4. AFib Patients Taking Digoxin Have Increased Risk of Death
• Complete ACC.17 Coverage
5. ACC Releases New Guidance For Syncope
   Journal of the American College of Cardiology
6. New Guidance Issued For Nonvalvular AFib Patients Taking Anticoagulants
   Journal of the American College of Cardiology
7. New Guidance Released For TAVR
   Journal of the American College of Cardiology
8. Study Looks at USPSTF vs. ACC/AHA Guidelines For Statin Therapy
   Journal of the American Medical Association
9. CASTLE-AF: Catheter Ablation vs. Conventional Therapy For Patients With AFib and LV Dysfunction
• Complete ESC 2017 Coverage
10. Focused Update of the Valvular Heart Disease Guideline Released
    Journal of the American College of Cardiology

Clinical Topics: Anticoagulation Management, Arrhythmias and Clinical EP, Cardiac Surgery, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Prevention, Valvular Heart Disease, Anticoagulation Management and Atrial Fibrillation, SCD/Ventricular Arrhythmias, Atrial Fibrillation/Supraventricular Arrhythmias, Cardiac Surgery and Arrhythmias, Cardiac Surgery and VHD, Nonstatins, Novel Agents, Statins, Interventions and Structural Heart Disease, Hypertension

Keywords: Anticoagulants, Digoxin, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Transcatheter Aortic Valve Replacement, Atrial Fibrillation, Heart Valve Diseases, Cardiovascular Diseases, Catheter Ablation, Syncope, Hypertension, Hospitalization

< Back to Listings